scholarly journals Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis

Drugs ◽  
2017 ◽  
Vol 77 (16) ◽  
pp. 1755-1768 ◽  
Author(s):  
Giancarlo Comi ◽  
Hans-Peter Hartung ◽  
Rajesh Bakshi ◽  
Ian M. Williams ◽  
Heinz Wiendl
Sign in / Sign up

Export Citation Format

Share Document